This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sarepta Therapeutics Inc (SRPT)

NASDAQ: Health Care

$21.98 -0.56 | -2.48%
07/11/14 - 4:00 PM ET
  • Prev Close: 22.54
  • Day's Open: 22.44
  • Volume: 2.18M
  • Avg Vol: 1.36M
  • Shares Outstanding: 40.68M
  • Mkt Cap: 1.05B
  • Div: --
  • Div Yield: --
  • P/E: N/A
  • EPS: -3.31
SRPT Day's Range
$21.80
$23.34
SRPT 52 Week Range
$12.12
$55.61
SRPT Business Summary
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases.View SRPT key stats
SRPT Performance as of Prev. Close
YTD
10.65%
3-Mo
-2.93%
1-Yr
-48.00%
3-Yr
127.68%
SRPT EPS Performance
1-Yr Ago
-3.31
2-Yrs Ago
-5.14
3-Yrs Ago
-0.11
SRPT Percentage in these ETFs
0.027%
0.009%
0.003%
0.000%
0.000%
SRPT News

SRPT Sarepta Therapeutics Inc

Analysts Ratings for SRPT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 6 7 4
Moderate Buy 2 2 2 2
Hold 4 4 4 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET SRPT ANALYST REPORT

Brokerage Partners

SRPT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs